Attached files
| file | filename |
|---|---|
| 10-Q - Emergent BioSolutions Inc. | form10-q033115.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-10.2 - BIOTHRAX CDC MOD - Emergent BioSolutions Inc. | exhibit10_2.htm |
| EX-10.1 - AMENDMENT TO CREDIT AGREEMENT - Emergent BioSolutions Inc. | exhibit10_1.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_1.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_1.htm |
EXHIBIT 12
|
Ratio of Earnings to Fixed Charges
|
||||||||||||||||||||||||
|
Year to Date
|
||||||||||||||||||||||||
|
|
September 30,
|
Year Ended December 31,
|
||||||||||||||||||||||
|
(in thousands)
|
2015
|
2014
|
2013
|
2012
|
2011
|
2010
|
||||||||||||||||||
|
|
||||||||||||||||||||||||
|
Pretax income from continuing operations (1)
|
$
|
41,888
|
|
$
|
53,062
|
$
|
44,243
|
$
|
37,446
|
$
|
38,849
|
$
|
77,880
|
|||||||||||
|
Fixed charges
|
||||||||||||||||||||||||
|
Interest expense
|
5,862
|
7,480
|
1,973
|
2,177
|
1,719
|
1,778
|
||||||||||||||||||
|
Debt issuance cost
|
1,182
|
3,274
|
319
|
67
|
135
|
113
|
||||||||||||||||||
|
Total fixed charges (2)
|
7,044
|
10,754
|
2,244
|
2,244
|
1,854
|
1,891
|
||||||||||||||||||
|
Noncontrolling interest in pretax income (3)
|
-
|
-
|
876
|
5,381
|
6,906
|
4,514
|
||||||||||||||||||
|
Capitalized interest (4)
|
2,127
|
2,530
|
1,973
|
2,171
|
1,713
|
1,796
|
||||||||||||||||||
|
Earnings ((1) + (2) -(3) -(4))
|
46,805
|
|
61,286
|
43,686
|
32,138
|
32,084
|
73,461
|
|||||||||||||||||
|
Fixed charges
|
7,044
|
10,754
|
2,292
|
2,244
|
1,854
|
1,891
|
||||||||||||||||||
|
Ratio of earnings to fixed charges
|
6.6
|
5.7
|
19.1
|
14.3
|
17.3
|
38.8
|
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||